Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of a multi factorial preventive scheme of action
(including fluvastatin and valsartan) to reduce the overall risk level in patients with
metabolic syndrome.